Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Glenmark Life Sciences Ltd - 543322 - Board Meeting Intimation for Inter Alia, To Consider And Approve The Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended 31St December, 2023.

 Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2024 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the third quarter and nine months ended 31st December, 2023.
15-01-2024
Bigul

Glenmark Life Sciences Ltd - 543322 - Clarification sought from Glenmark Life Sciences Ltd

 The Exchange has sought clarification from Glenmark Life Sciences Ltd on January 3, 2024, with reference to Movement in Volume. The reply is awaited.
03-01-2024
Bigul

Glenmark Life Sciences Ltd - 543322 - Clarification On Increase In Volume

 Clarification on increase in Volume
03-01-2024
Bigul

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Monitoring Agency Report for the quarter ended 30th September, 2023
13-11-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Transcript of Earnings Calls.
25-10-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2023-24 Earnings Call held on 20th October, 2023 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320231020149273.mp3
21-10-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Investor Presentation Q2 - FY 23-24
20-10-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Press Release and Management Discussion & Analysis is attached.
20-10-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Board Meeting Outcome for Unaudited Financial Results For The Second Quarter And Half Year Ended September 30, 2023

 Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2023. The said meeting of the Board commenced at 10.30 a.m. and concluded at 12.45 p.m. The copy of the said results and Limited Review Report of the Auditors is enclosed herewith.
20-10-2023
Bigul

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Enclosed please find herewith the details of Earnings Call slated for Friday, October 20, 2023 at 4:00 p.m. - 5:00 p.m. (IST), for your information and record.
16-10-2023
Next Page
Close

Let's Open Free Demat Account